Patient Counseling for Apremilast Therapy
Patients starting apremilast must understand the 5-day dose titration schedule to minimize gastrointestinal side effects, be counseled about potential depression/mood changes, and be monitored for weight loss throughout treatment. 1, 2
Dosing Instructions
Start with gradual dose escalation over 5 days to reduce GI symptoms 1, 2:
- Day 1: 10 mg AM only
- Day 2: 10 mg AM and PM
- Day 3: 10 mg AM, 20 mg PM
- Day 4: 20 mg AM and PM
- Day 5: 20 mg AM, 30 mg PM
- Day 6 onward: 30 mg twice daily (maintenance dose)
Key administration points:
- Take with or without food 2
- Do not crush, split, or chew tablets 2
- For severe renal impairment (creatinine clearance <30 mL/min): reduce to 30 mg once daily and use only AM titration schedule 1, 2
Expected Side Effects and Management
Most common adverse effects occur within the first 2 weeks and are typically mild 1:
Gastrointestinal symptoms (most frequent):
- Diarrhea and nausea affect most patients initially
- 70-80% occur in first 2 weeks
- 75-80% are mild severity
- 60-65% resolve within first month 1
Critical warning for elderly patients (≥65 years): Higher risk of dehydration and complications from GI side effects; may require hospitalization 1, 2. Monitor closely and maintain adequate hydration.
Other common effects:
- Headache
- Upper respiratory tract infections
- Nasopharyngitis 1
If severe diarrhea, nausea, or vomiting develops: Contact healthcare provider immediately for possible dose reduction or temporary suspension 2
Mental Health Monitoring
Depression risk requires proactive counseling before starting therapy 1, 2:
- Approximately 1% of patients report depression 1
- Discuss this risk explicitly before initiating treatment 1
- Patients, caregivers, and families must watch for emergence or worsening of depression, suicidal thoughts, or mood changes 2
- Contact healthcare provider immediately if mood changes occur 2
- Carefully weigh risks vs benefits in patients with history of depression or suicidal ideation 2
Weight Monitoring
Regular weight checks are mandatory throughout treatment 1:
- 12% of patients experience 5-10% body weight decrease 1
- If weight loss >5% from baseline occurs: consider discontinuing apremilast 1
- Monitor weight at each visit
Drug Interactions
Avoid strong cytochrome P450 inducers as they reduce apremilast efficacy 1, 2:
- Rifampin
- Phenobarbital
- Carbamazepine
- Phenytoin
Review all medications before starting and periodically during treatment 1
Advantages of Apremilast
No laboratory monitoring required - a key benefit distinguishing apremilast from other systemic therapies 1. However, routine screening can be considered on individual basis 1.
Pregnancy Considerations
- Use only if benefit justifies potential fetal risk 1
- Pregnancy registry available: 1-877-311-8972 2
- Inform prescriber immediately if pregnancy occurs or is suspected 2
Timeline for Response
Expect gradual improvement:
- Some patients notice pruritus and skin discomfort improvement as early as week 2 3
- Meaningful joint improvement typically by week 2-16 3, 4
- Full assessment of efficacy should occur at 16 weeks
- Benefits are sustained with continued treatment through 52+ weeks 4
When to Contact Healthcare Provider
Immediate contact needed for: